Skip to main content
. 2022 Nov 9;23(22):13794. doi: 10.3390/ijms232213794

Figure 5.

Figure 5

Potential of patient-specific iPSC-derived RPEs for large-scale production. Patient-derived iPSCs can be easily obtained from patients’ somatic cells and expanded infinitely in culture, allowing the large-scale production of iPSC-derived RPEs to meet the demand of disease modeling, pathogenic mechanism investigation, and drug testing/screening. (Image credit—Created with BioRender.com).